BUI Publications 2013

Osman NI, Chapple CR, Abrams P, Dmochowski R, Haab F, Nitti V, Koelbl H, van Kerrebroeck P, Wein AJ. Detrusor Underactivity and the Underactive Bladder: A New Clinical Entity? A Review of Current Terminology, Definitions, Epidemiology, Aetiology, and Diagnosis. Eur Urol. 2013 Oct 26.

Burden H, Warren K, Abrams P. Diagnosis of male incontinence. Curr Opin Urol. 2013 Nov;23(6):509-14.

Chapple CR, Abrams P, Andersson KE, Radziszewski P, Masuda T, Small M, Kuwayama T, Deacon S. Phase II Study on the Efficacy and Safety of the EP1 Receptor Antagonist ONO-8539 for Nonneurogenic Overactive Bladder Syndrome. J Urol. 2013 Sep 7

Yeo EK, Hashim H, Abrams P. New therapies in the treatment of overactive bladder. Expert Opin Emerg Drugs. 2013 Sep;18(3):319-37.

Hart WM, Abrams P, Munro V, Retsa P, Nazir J. Cost-effectiveness analysis of solifenacin versus oxybutynin immediate-release in the treatment of patients with overactive bladder in the United Kingdom. J Med Econ. 2013 Oct;16(10):1246-54.

Wai CY, Curto TM, Zyczynski HM, Stoddard AM, Burgio KL, Brubaker L, Rickey LM, Menefee SA; Urinary Incontinence Treatment Network. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstet Gynecol. 2013 May;121(5):1009-16.

Abrams P, Chapple C, Khoury S, Roehrborn C, de la Rosette J; International Consultation on New Developments in Prostate Cancer and Prostate Diseases. Evaluation and treatment of lower urinary tract symptoms in older men. J Urol. 2013 Jan;189(1 Suppl):S93-S101.

Ismail M, Mackenzie K, Hashim H. Contemporary treatment options for chronic prostatitis/chronic pelvic pain syndrome. Drugs Today (Barc). 2013 Jul;49(7):457-62.

Hofmeester I, Kollen BJ, Steffens MG, Bosch JL, Drake MJ, Weiss JP, Blanker MH. The association between nocturia and nocturnal polyuria in clinical and epidemiological studies: a systematic review and meta-analyses. J Urol. 2013 Oct 29.

Carugo D, Elmahdy M, Zhao X, Drake MJ, Zhang X, Clavica F. An artificial model for studying fluid dynamics in the obstructed and stented ureter. Conf Proc IEEE  Eng Med Biol Soc. 2013;2013:5335-8.

Sadananda P, Drake MJ, Paton JF, Pickering AE. A functional analysis of the influence of β3-adrenoceptors on the rat micturition cycle. J Pharmacol Exp Ther. 2013 Nov;347(2):506-15. doi: 10.1124/jpet.113.207340. Epub 2013 Sep 5. PubMed

Lewis DA, Brown R, Williams J, White P, Jacobson SK, Marchesi JR, Drake MJ. The human urinary microbiome; bacterial DNA in voided urine of asymptomatic adults. Front Cell Infect Microbiol. 2013 Aug 15;3:41.

van Kerrebroeck P, Chapple C, Drogendijk T, Klaver M, Sokol R, Speakman M, Traudtner K, Drake MJ; NEPTUNE Study Group. Combination Therapy with Solifenacin  and Tamsulosin Oral Controlled Absorption System in a Single Tablet for Lower Urinary Tract Symptoms in Men: Efficacy and Safety Results from the Randomised Controlled NEPTUNE Trial. Eur Urol. 2013 Dec;64(6):1003-12.

Vahabi B, Parsons BA, Doran O, Rhodes A, Dean S, Drake MJ. TRPM8 agonists modulate contraction of the pig urinary bladder. Can J Physiol Pharmacol. 2013 Jul;91(7):503-9. doi: 10.1139/cjpp-2012-0406. Epub 2013 Jan 30.

Soler R, Andersson KE, Chancellor MB, Chapple CR, de Groat WC, Drake MJ, Gratzke C, Lee R, Cruz F. Future direction in pharmacotherapy for non-neurogenic  male lower urinary tract symptoms. Eur Urol. 2013 Oct;64(4):610-21.

Delgado D, White P, Trochez R, Drake MJ. A pilot randomised controlled trial of the pelvic toner device in female stress urinary incontinence. Int Urogynecol  J 2013 Oct;24(10):1739-45.

Vahabi B, Sellers DJ, Bijos DA, Drake MJ. Phasic contractions in urinarybladder from juvenile versus adult pigs. PLoS One. 2013;8(3)

Weiss JP, Blaivas JG, Blanker MH, Bliwise DL, Dmochowski RR, Drake M, DuBeau  CE, Hijaz A, Rosen RC, Van Kerrebroeck PE, Wein AJ. The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy. BJU Int. 2013 May;111(5):700-16.

Van der Aa F, Drake MJ, Kasyan GR, Petrolekas A, Cornu JN; Young Academic Urologists Functional Urology Group. The artificial urinary sphincter after a quarter of a century: a critical systematic review of its use in male non-neurogenic incontinence. Eur Urol. 2013 Apr;63(4):681-9.

Biernacka KM, Uzoh CC, Zeng L, Persad RA, Bahl A, Gillatt D, Perks CM, Holly JM. Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2. Endocr Relat Cancer. 2013 Sep 11;20(5):741-51

Khalid T, White P, De Lacy Costello B, Persad R, Ewen R, Johnson E, Probert CS, Ratcliffe N. A pilot study combining a GC-sensor device with a statistical model for the identification of bladder cancer from urine headspace. PLoS One. 2013 Jul 8;8(7)

Dickinson L, Ahmed HU, Kirkham AP, Allen C, Freeman A, Barber J, Hindley RG, Leslie T, Ogden C, Persad R, Winkler MH, Emberton M; INDEX Study Group. A multi-centre prospective development study evaluating focal therapy using high intensity focused ultrasound for localised prostate cancer: The INDEX study. Contemp Clin Trials. 2013 Sep;36(1):68-80.

Parsons BA, Kalejaiye O, Mohammed M, Persad RA. The penile tourniquet. Asian J Androl. 2013 May;15(3):364-7

Eylert MF, Hounsome L, Verne J, Bahl A, Jefferies ER, Persad RA. Prognosis is deteriorating for upper tract urothelial cancer: data for England 1985-2010. BJU Int. 2013 Jul;112(2)

Philippou P, Payne D, Davenport K, Timoney AG, Keeley FX. Does previous failed ESWL have a negative impact of on the outcome of ureterorenoscopy? A matched pair analysis. Urolithiasis. 2013 Nov;41(6):531-8.

Goh MH, Kastner C, Khan S, Thomas P, Timoney AG. First experiences with the spanner™ temporary prostatic stent for prostatic urethral obstruction. Urol Int.  2013;91(4):384-90

Calvert RC, Wong KY, Chitale SV, Irving SO, Nagarajan M, Biyani CS, Browning AJ, Young JG, Timoney AG, Keeley FX, Burgess NA. Multi-length or 24 cm ureteric stent? A multicentre randomised comparison of stent-related symptoms using a validated questionnaire. BJU Int. 2013 Jun;111(7):1099-104.

Sanguedolce F, Millán-Rodriguez F, Santillana-Altimira JM, Fantova-Alonso A, Sánchez-Martín FM, Angerri-Feu O, Lopez Martinez JM, Keeley FX, Joshi HB, Villavicencio-Mávrich H. The Spanish Linguistic Validation of the Ureteral Stent Symptom Questionnaire. J Endourol. 2013 Nov 9.

Hotston MR, Keeley FX. Laparoscopic partial nephrectomy without ischemia. Arch Esp Urol. 2013 Jan-Feb;66(1):146-51. Review.

Redaniel MT, Martin RM, Gillatt D, Wade J, Jeffreys M. Time from diagnosis to surgery and prostate cancer survival: a retrospective cohort study. BMC Cancer. 2013 Nov 27;13(1):559.

Baker SC, Stahlschmidt J, Oxley J, Hinley J, Eardley I, Marsh F, Gillatt D, Fulford S, Southgate J. Nerve hyperplasia: a unique feature of ketamine cystitis. Acta Neuropathol Commun. 2013 Oct 8;1(1):64.

Murphy DG, Ahlering T, Catalona WJ, Crowe H, Crowe J, Clarke N, Cooperberg M,  Gillatt D, Gleave M, Loeb S, Roobol M, Sartor O, Pickles T, Wootten A, Walsh PC,  Costello AJ. The Melbourne Consensus Statement on the Early Detection of Prostate Cancer. BJU Int. 2013 Nov 8.

Biernacka KM, Uzoh CC, Zeng L, Persad RA, Bahl A, Gillatt D, Perks CM, Holly JM. Hyperglycaemia-induced chemoresistance of prostate cancer cells due to IGFBP2. Endocr Relat Cancer. 2013 Sep 11;20(5):741-51.